"10.1371_journal.pmed.0010064","plos medicine","2004-12-28T00:00:00Z","Emmanouil Papasavvas; Jay R Kostman; Karam Mounzer; Robert M Grant; Robert Gross; Cele Gallo; Livio Azzoni; Andrea Foulkes; Brian Thiel; Maxwell Pistilli; Agnieszka Mackiewicz; Jane Shull; Luis J Montaner","The Wistar Institute, Philadelphia, Pennsylvania, United States of America; Philadelphia Field Initiating Group for HIV-1 Trials and the Division of Infectious Diseases, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America; Philadelphia Field Initiating Group for HIV-1 Trials, Philadelphia, Pennsylvania, United States of America; The Gladstone Institute of Virology and Immunology, University of California, San Francisco, California, United States of America; Center for Clinical Epidemiology and Biostatistics and the Division of Infectious Diseases, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America; Department of Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America","EP, JRK, KM, RMG, JS, and LJM designed the study. EP, JRK, RMG, LA, AF, BT, MP, AM, and LJM analyzed the data. EP, JRK, KM, RMG, RG, CG, LA, AF, BT, MP, AM, JS, and LJM contributed to writing the paper.","RMG is a paid consultant for the Bayer Guidelines Project, which develops algorithms for interpretation of drug resistance genotyping assays; received honoraria and research support from ViroLogic and Visible Genetics; received honoraria for speaking at educational programs supported by ViroLogic, Visible Genetics, GlaxoSmithKline, Bristol-Myers Squibb, Roche Pharmaceuticals, and Agouron Pharmaceuticals; and directs a nonprofit academic laboratory at the Gladstone Institute of Virology and Immunology that has provided services for clinical research supported by grants to the University of California from Merck, GlaxoSmithKline, Bristol-Myers Squibb, Boehringer Ingelheim, Roche, Abbott, Agouron Pharmaceuticals, Gilead, Visible Genetics, and Chiron. RG receives support for his HIV research from Agouron Pharmaceuticals, GlaxoSmithKline, and Bristol-Myers Squibb and serves as a consultant to GlaxoSmithKline; all relationships have been disclosed to the University of Pennsylvania, which deemed them not to constitute a conflict of interest.","2004","12","Emmanouil Papasavvas","EP",13,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
